Simultaneous high PD-L1 and low VEGFR2 expression is associated with better overall survival in rectal cancer
Yun Ding(Nanchang University), Jingting Jiang(Soochow University), Weibin Huang(Xiamen University), Qi Wang(Dalian Medical University), Zhuojun Zheng(Soochow University), Wei Wei(Zhujiang Hospital), Yuanyuan Fu(University of Hawaiʻi at Mānoa), Dachuan Zhang(Soochow University), Wendong Gu(Soochow University), Jiajia He(Fujian Normal University), Xiao Zheng(Shanxi Medical University), Yingting Liu(Amgen (United States))
Cited by 3
Related Papers
Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial
|Journal of Clinical Oncology|2018|976
A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling
|Molecular Cancer|2019|718
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216